Jafron BiomedicalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Jafron BiomedicalLtd has a total shareholder equity of CN¥3.0B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 54.7%. Its total assets and total liabilities are CN¥5.5B and CN¥2.4B respectively. Jafron BiomedicalLtd's EBIT is CN¥807.0M making its interest coverage ratio -51.7. It has cash and short-term investments of CN¥2.8B.
Key information
54.7%
Debt to equity ratio
CN¥1.67b
Debt
| Interest coverage ratio | -51.7x |
| Cash | CN¥2.76b |
| Equity | CN¥3.05b |
| Total liabilities | CN¥2.41b |
| Total assets | CN¥5.46b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300529's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥1.0B).
Long Term Liabilities: 300529's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: 300529 has more cash than its total debt.
Reducing Debt: 300529's debt to equity ratio has increased from 0% to 54.7% over the past 5 years.
Debt Coverage: 300529's debt is well covered by operating cash flow (73.8%).
Interest Coverage: 300529 earns more interest than it pays, so coverage of interest payments is not a concern.